NANO.JK(NANO.JK)
NANO.JK
PT Nanotech Indonesia Global Tbk specializes in advanced medical devices, particularly in the fields of diagnostics and surgical instruments. The company holds a competitive edge through its proprietary nanotechnology applications that enhance device performance, primarily serving the Southeast Asian market.
Nanotech generates revenue through the sale of innovative medical devices that leverage nanotechnology for improved efficacy and safety. Its pricing power is supported by patents on proprietary technologies and strong relationships with hospitals and clinics across Indonesia and neighboring countries.
Regulatory approvals for new medical devices
Market adoption rates of nanotechnology in healthcare
Partnerships with healthcare providers
Changes in healthcare spending in Southeast Asia
Technological disruption from emerging medical technologies
Regulatory changes affecting product approvals
Increasing competition from global medical device manufacturers
Potential market entry of low-cost alternatives
Low ROE (1.2%) may indicate inefficiencies in capital utilization
Potential liquidity risks if cash flow declines significantly
moderate - As a healthcare device manufacturer, demand is somewhat insulated from economic downturns, but overall spending in healthcare can be influenced by GDP growth.
Interest rates affect financing costs for R&D and capital expenditures. Higher rates could increase borrowing costs, impacting future investments and valuations.
minimal - The company has a low debt/equity ratio of 0.11, indicating limited reliance on external financing.
growth - Investors may be drawn to the company's innovative technology and potential for market expansion.
high - The stock has shown significant price fluctuations, particularly with a 6-month return of -40.9%.